Cardiol Therapeutics Statistics

Total Valuation

CRDL has a market cap or net worth of $114.60 million. The enterprise value is $79.84 million.

Market Cap	114.60M
Enterprise Value	79.84M

Important Dates

The next estimated earnings date is Monday, May 13, 2024, after market close.

Earnings Date	May 13, 2024
Ex-Dividend Date	n/a

Share Statistics

CRDL has 65.11 million shares outstanding. The number of shares has increased by 3.13% in one year.

Shares Outstanding	65.11M
Shares Change (YoY)	+3.13%
Shares Change (QoQ)	+1.05%
Owned by Insiders (%)	4.42%
Owned by Institutions (%)	13.41%
Float	n/a

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	4.06
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 4.36, with a Debt / Equity ratio of 0.01.

Current Ratio	4.36
Quick Ratio	4.24
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -76.30% and return on invested capital (ROIC) is -104.80%.

Return on Equity (ROE)	-76.30%
Return on Assets (ROA)	-62.60%
Return on Capital (ROIC)	-104.80%
Revenue Per Employee	n/a
Profits Per Employee	-$1.28M
Employee Count	22
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +151.46% in the last 52 weeks. The beta is 0.71, so CRDL's price volatility has been lower than the market average.

Beta (1Y)	0.71
52-Week Price Change	+151.46%
50-Day Moving Average	1.67
200-Day Moving Average	1.12
Relative Strength Index (RSI)	50.63
Average Volume (30 Days)	393,846

Short Selling Information

The latest short interest is 326,642, so 0.50% of the outstanding shares have been sold short.

Short Interest	326,642
Short Previous Month	272,976
Short % of Shares Out	0.50%
Short % of Float	n/a
Short Ratio (days to cover)	0.88

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-29.79M
Pretax Income	-28.13M
Net Income	-28.13M
EBITDA	-27.88M
EBIT	-28.13M
Earnings Per Share (EPS)	-$0.44

Full Income Statement

Balance Sheet

The company has $34.93 million in cash and $174,340 in debt, giving a net cash position of $34.76 million or $0.53 per share.

Cash & Cash Equivalents	34.93M
Total Debt	174,340
Net Cash	34.76M
Net Cash Per Share	$0.53
Equity / Book Value	28.25M
Book Value Per Share	0.43
Working Capital	27.86M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$25.18 million and capital expenditures -$64,312, giving a free cash flow of -$25.24 million.

Operating Cash Flow	-25.18M
Capital Expenditures	-64,312
Free Cash Flow	-25.24M
FCF Per Share	-$0.39

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

CRDL does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-3.13%
Shareholder Yield	-3.13%
Earnings Yield	-24.54%
FCF Yield	-22.03%

Analyst Forecast

The average price target for CRDL is $6.00, which is 240.91% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$6.00
Price Target Difference	240.91%
Analyst Consensus	Strong Buy
Analyst Count	3
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1